Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 May;38(5):1123–1128. doi: 10.1128/aac.38.5.1123

Effects of pentamidine isethionate on Saccharomyces cerevisiae.

G Ludewig 1, J M Williams 1, Y Li 1, C Staben 1
PMCID: PMC188161  PMID: 8067749

Abstract

We used Saccharomyces cerevisiae as a model system in which to examine the mechanism of action of the anti-Pneumocystis drug pentamidine. Pentamidine at low concentrations inhibited S. cerevisiae growth on nonfermentable carbon sources (50% inhibitory concentration [IC50] of 1.25 micrograms/ml in glycerol). Pentamidine inhibited growth on fermentable energy sources only at much higher concentrations (IC50 of 250 micrograms/ml in glucose). Inhibition at low pentamidine concentrations in glycerol was due to cytostatic activity rather than cytotoxic or mutagenic activity. Pentamidine also rapidly inhibited respiration by intact yeast cells, although inhibitory concentrations were much higher than those inhibitory to growth (IC50 of 100 micrograms/ml for respiration). Pentamidine also induced petite mutations, although only at concentrations much higher than those required for growth inhibition. These results suggest that a function essential for respiratory growth is inhibited by pentamidine and that pentamidine affects mitochondrial processes. We propose the hypothesis that the primary cellular target of pentamidine in S. cerevisiae is the mitochondrion.

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beattie D. S., Marcelo-Baciu R. M. Time and concentration dependence of the dicyclohexylcarbodiimide inhibition of proton movements in the cytochrome bc1 complex from yeast mitochondria reconstituted into proteoliposomes. J Bioenerg Biomembr. 1991 Aug;23(4):665–678. doi: 10.1007/BF00785816. [DOI] [PubMed] [Google Scholar]
  2. Berger B. J., Hall J. E., Tidwell R. R. The distribution of multiple doses of pentamidine in rats. Pharmacol Toxicol. 1990 Mar;66(3):234–236. doi: 10.1111/j.1600-0773.1990.tb00740.x. [DOI] [PubMed] [Google Scholar]
  3. Berger B. J., Naiman N. A., Hall J. E., Peggins J., Brewer T. G., Tidwell R. R. Primary and secondary metabolism of pentamidine by rats. Antimicrob Agents Chemother. 1992 Sep;36(9):1825–1831. doi: 10.1128/aac.36.9.1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bowman E. J. Comparison of the vacuolar membrane ATPase of Neurospora crassa with the mitochondrial and plasma membrane ATPases. J Biol Chem. 1983 Dec 25;258(24):15238–15244. [PubMed] [Google Scholar]
  5. Bruns T. D., Vilgalys R., Barns S. M., Gonzalez D., Hibbett D. S., Lane D. J., Simon L., Stickel S., Szaro T. M., Weisburg W. G. Evolutionary relationships within the fungi: analyses of nuclear small subunit rRNA sequences. Mol Phylogenet Evol. 1992 Sep;1(3):231–241. doi: 10.1016/1055-7903(92)90020-h. [DOI] [PubMed] [Google Scholar]
  6. Comley J. C., Mullin R. J., Wolfe L. A., Hanlon M. H., Ferone R. Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii. Antimicrob Agents Chemother. 1991 Oct;35(10):1965–1974. doi: 10.1128/aac.35.10.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Conte J. E., Jr, Upton R. A., Phelps R. T., Wofsy C. B., Zurlinden E., Lin E. T. Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS. J Infect Dis. 1986 Dec;154(6):923–929. doi: 10.1093/infdis/154.6.923. [DOI] [PubMed] [Google Scholar]
  8. Cory M., Tidwell R. R., Fairley T. A. Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) J Med Chem. 1992 Feb 7;35(3):431–438. doi: 10.1021/jm00081a003. [DOI] [PubMed] [Google Scholar]
  9. Cubría J. C., Ordóez D., Alvarez-Bujidos M. L., Negro A., Ortíz A. I. Inhibition of diamine oxidase from porcine kidney by pentamidine and other aminoguanidine compounds. Comp Biochem Physiol B. 1991;100(3):543–546. doi: 10.1016/0305-0491(91)90217-2. [DOI] [PubMed] [Google Scholar]
  10. Damper D., Patton C. L. Pentamidine transport and sensitivity in brucei-group trypanosomes. J Protozool. 1976 May;23(2):349–356. doi: 10.1111/j.1550-7408.1976.tb03787.x. [DOI] [PubMed] [Google Scholar]
  11. Dykstra C. C., Tidwell R. R. Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J Protozool. 1991 Nov-Dec;38(6):78S–81S. [PubMed] [Google Scholar]
  12. Edman J. C., Edman U., Cao M., Lundgren B., Kovacs J. A., Santi D. V. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8625–8629. doi: 10.1073/pnas.86.22.8625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Edman J. C., Kovacs J. A., Masur H., Santi D. V., Elwood H. J., Sogin M. L. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature. 1988 Aug 11;334(6182):519–522. doi: 10.1038/334519a0. [DOI] [PubMed] [Google Scholar]
  14. Edman U., Edman J. C., Lundgren B., Santi D. V. Isolation and expression of the Pneumocystis carinii thymidylate synthase gene. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6503–6507. doi: 10.1073/pnas.86.17.6503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Edwards K. J., Jenkins T. C., Neidle S. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. Biochemistry. 1992 Aug 11;31(31):7104–7109. doi: 10.1021/bi00146a011. [DOI] [PubMed] [Google Scholar]
  16. Frommel T. O., Balber A. E. Flow cytofluorimetric analysis of drug accumulation by multidrug-resistant Trypanosoma brucei brucei and T. b. rhodesiense. Mol Biochem Parasitol. 1987 Nov;26(1-2):183–191. doi: 10.1016/0166-6851(87)90142-3. [DOI] [PubMed] [Google Scholar]
  17. Grant A., Macgregor A. M., Burchell A. Characterization of glucose-6-phosphatase in hepatocytes. Effects of amiloride and pentamidine. Biochem Pharmacol. 1991 Dec 11;42 (Suppl):S27–S32. doi: 10.1016/0006-2952(91)90388-l. [DOI] [PubMed] [Google Scholar]
  18. Hatfield C., Kasarskis A., Staben C. Pentamidine sensitivity and resistance in Saccharomyces cerevisiae as a model for pentamidine effects on Pneumocystis carinii. J Protozool. 1991 Nov-Dec;38(6):70S–71S. [PubMed] [Google Scholar]
  19. Hughes W. T. Animal models for Pneumocystis carinii pneumonia. J Protozool. 1989 Jan-Feb;36(1):41–45. doi: 10.1111/j.1550-7408.1989.tb02688.x. [DOI] [PubMed] [Google Scholar]
  20. Hughes W. T., Gray V. L., Gutteridge W. E., Latter V. S., Pudney M. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1990 Feb;34(2):225–228. doi: 10.1128/aac.34.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hughes W. T. Prevention and treatment of Pneumocystis carinii pneumonia. Annu Rev Med. 1991;42:287–295. doi: 10.1146/annurev.me.42.020191.001443. [DOI] [PubMed] [Google Scholar]
  22. Libby P. R., Porter C. W. Inhibition of enzymes of polyamine back-conversion by pentamidine and berenil. Biochem Pharmacol. 1992 Aug 18;44(4):830–832. doi: 10.1016/0006-2952(92)90424-h. [DOI] [PubMed] [Google Scholar]
  23. Pesanti E. L., Cox C. Metabolic and synthetic activities of Pneumocystis carinii in vitro. Infect Immun. 1981 Dec;34(3):908–914. doi: 10.1128/iai.34.3.908-914.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Reynolds I. J., Aizenman E. Pentamidine is an N-methyl-D-aspartate receptor antagonist and is neuroprotective in vitro. J Neurosci. 1992 Mar;12(3):970–975. doi: 10.1523/JNEUROSCI.12-03-00970.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Salamone F. R., Cunha B. A. Update on pentamidine for the treatment of Pneumocystis carinii pneumonia. Clin Pharm. 1988 Jul;7(7):501–510. [PubMed] [Google Scholar]
  26. Shapiro T. A., Englund P. T. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc Natl Acad Sci U S A. 1990 Feb;87(3):950–954. doi: 10.1073/pnas.87.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stauffert I., Paulini H., Steinmann U., Sippel H., Estler C. J. Investigations on mutagenicity and genotoxicity of pentamidine and some related trypanocidal diamidines. Mutat Res. 1990 Oct;245(2):93–98. doi: 10.1016/0165-7992(90)90006-6. [DOI] [PubMed] [Google Scholar]
  28. Stringer J. R., Edman J. C., Cushion M. T., Richards F. F., Watanabe J. The fungal nature of Pneumocystis. J Med Vet Mycol. 1992;30 (Suppl 1):271–278. doi: 10.1080/02681219280000961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stringer S. L., Stringer J. R., Blase M. A., Walzer P. D., Cushion M. T. Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol. 1989 May;68(4):450–461. doi: 10.1016/0014-4894(89)90130-6. [DOI] [PubMed] [Google Scholar]
  30. Ulery T. L., Mangus D. A., Jaehning J. A. The yeast IMP1 gene is allelic to GAL2. Mol Gen Genet. 1991 Nov;230(1-2):129–135. doi: 10.1007/BF00290660. [DOI] [PubMed] [Google Scholar]
  31. Van Voorhis W. C. Therapy and prophylaxis of systemic protozoan infections. Drugs. 1990 Aug;40(2):176–202. doi: 10.2165/00003495-199040020-00002. [DOI] [PubMed] [Google Scholar]
  32. Vinet B., Comtois R., Gervais A., Lemieux C. Clinical usefulness of high-pressure liquid chromatographic determination of serum pentamidine in AIDS patients. Clin Biochem. 1992 Apr;25(2):93–97. doi: 10.1016/0009-9120(92)80050-q. [DOI] [PubMed] [Google Scholar]
  33. Walzer P. D. Pneumocystis carinii--new clinical spectrum? N Engl J Med. 1991 Jan 24;324(4):263–265. doi: 10.1056/NEJM199101243240411. [DOI] [PubMed] [Google Scholar]
  34. Waring M. J. The effects of antimicrobial agents on ribonucleic acid polymerase. Mol Pharmacol. 1965 Jul;1(1):1–13. [PubMed] [Google Scholar]
  35. Yoshida Y. Ultrastructural studies of Pneumocystis carinii. J Protozool. 1989 Jan-Feb;36(1):53–60. doi: 10.1111/j.1550-7408.1989.tb02696.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES